Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(11 sites)
United States
California Cancer Associates-Encintas, Encinitas, California Providence/St. Joe Cancer Institute/Crosson Cancer Institute, Fullerton, California Winship Cancer Institute of Emory University, Atlanta, Georgia Dana Farber Cancer Institue, Boston, Massachusetts Karmanos Cancer Institute, Detroit, Michigan Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada Gabrail Cancer Center Research, Canton, Ohio OU Health, Oklahoma City, Oklahoma Sarah Cannon Research Center, Nashville, Tennessee North Houston Cancer Clinics, Huntsville, Texas Virginia Cancer Specialists, Fairfax, Virginia